Anika Therapeutics | ANIK - Assets

Stock Price
14.40
Daily Change
0.04 0.28%
Monthly
39.81%
Yearly
-15.44%
Q1 Forecast
13.92

Anika Therapeutics reported $189.44M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Agenus USD 233.89M 48.67M Sep/2025
Agios Pharmaceuticals USD 1.3B 88.48M Dec/2025
Anika Therapeutics USD 189.44M 1.76M Sep/2025
Arrowhead Research USD 1.6B 218.89M Dec/2025
Enanta Pharmaceuticals USD 329.5M 48.77M Dec/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Heron Therapeutics USD 248.95M 16.86M Sep/2025
Insmed USD 2.26B 96.18M Dec/2025
Integra LifeSciences USD 3.6B 44.45M Dec/2025
Intrexon USD 73.16M 77.88M Jun/2024
J&J USD 199.21B 6.39B Dec/2025
Karyopharm Therapeutics USD 96.23M 8.65M Sep/2025
Ligand Pharmaceuticals USD 1.56B 83.86M Dec/2025
MacroGenics USD 270.76M 25.34M Sep/2025
Merit Medical Systems USD 2.69B 54.92M Dec/2025
Rigel Pharmaceuticals USD 242.53M 35.8M Sep/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Smith & Nephew USD 10.69B 150M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Surmodics USD 178.56M 1.15M Sep/2024
Veracyte USD 1.41B 38.23M Dec/2025
Xencor USD 875.5M 6.68M Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025